GlassScriptPhysician profile
Leyda Callejas
NPI 1750687059
$2,356.89
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,123 · 2020: $174 · 2022: $59.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $463.90 | 2019 | |
| Novo Nordisk INC | $358.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $226.67 | 2019 | |
| Lilly USA, LLC | $216.19 | 2019-2020 | |
| Abbott Laboratories | $175.25 | 2019 | |
| Medtronic Minimed, INC. | $116.89 | 2019 | |
| Corcept Therapeutics | $103.74 | 2019 | |
| Shire North American Group INC | $90.07 | 2019 | |
| Merck Sharp & Dohme LLC | $80.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.87 | 2019 | |
| Medtronic, INC. | $59.53 | 2022 | |
| Opko Pharmaceuticals, LLC | $59.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.51 | 2019 | |
| Amgen INC. | $57.69 | 2019 | |
| Ibsa Pharma INC. | $56.40 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $48.30 | 2019 | |
| Amarin Pharma, INC. | $34.62 | 2019 | |
| Radius Health, INC. | $19.14 | 2019 | |
| Hikma Pharmaceuticals USA | $15.30 | 2019 | |
| Senseonics, Incorporated | $15.00 | 2019 | |
| Abbvie INC. | $14.38 | 2019 | |
| Lifescan, INC. | $13.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leyda Callejas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.